Lb Pharmaceuticals (LBRX) Shares Issued (2024 - 2026)

Lb Pharmaceuticals' Shares Issued history runs 3 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• On a quarterly basis, Shares Issued changed N/A year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $3.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.6 million, up 466.3% from the prior year.
• Shares Issued improved to $3.0 million in Q1 2026 per LBRX's latest filing, from $2.6 million in the prior quarter.
• Across five years, Shares Issued topped out at $3.0 million in Q1 2026 and bottomed at $457000.0 in Q4 2024.
• The 3-year median for Shares Issued is $2.4 million (2025), against an average of $2.1 million.
• Biggest YoY gain for Shares Issued was 466.3% in 2025; the steepest drop was 466.3% in 2025.
• Year by year, Shares Issued stood at $457000.0 in 2024, then jumped by 466.3% to $2.6 million in 2025, then increased by 17.23% to $3.0 million in 2026.
• Per Business Quant, the three latest LBRX Shares Issued figures stand at $3.0 million (Q1 2026), $2.6 million (Q4 2025), and $2.2 million (Q3 2025).